Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Children's Hospital Los Angeles
- Study ID
- NCT06526260
- Status
- Recruiting
Conditions
- Social Anxiety Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - 22 Years
- Healthy Volunteers
- Accepted
Interventions
- Very Brief Exposure to Facial Expressions — BEHAVIORALIn Very Brief Exposure (VBE): a series of rapid micro- exposures to images depicting feared stimuli (e.g., for SAD, judgmental faces). Each image is followed by a masking stimulus to prevent its conscious recognition. This sequence of image-mask stimuli is repeated many times in an exposure session.
Study Details
The goal of this clinical trial is to identify the circuit activations by very brief exposure (VBE) among youth with social anxiety disorder (SAD) in order to develop a novel intervention for those with SAD. The secondary objectives of this study are to measure the effect of VBE on subjective fear ratings, and participants' awareness and tolerance of the exposure stimuli. * The primary outcome of this study is the mean activation of frontostriatal and prefrontal brain regions to facial stimuli, as measured by Blood Oxygen Level Dependent (BOLD) response, in 4 regions of interest during the magnetic resonance imaging (MRI). * Another primary outcome of the study is to identify networks of regions subserving emotion regulation and attention, as measured by BOLD response of corresponding brain regions. Secondary Outcomes -The secondary outcome of this study is the fear induced by exposure to facial expression stimuli as measured by a 4-point fear scale during the functional magnetic resonance imaging (fMRI) after each block of 10 facial expression stimuli trials. Participants will participate in an interview where they will answer questions both inside and outside of the MRI scan. Participants will be asked to rate on a scale the imagines they see while undergoing MRI scan.
Key Dates
- Start date
- Aug 14, 2024
- Status verified
- Dec 2025
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Image Exposure ArmParticipants will see various images of facial expressions on a computer screen and provide various rating scores about them.
Primary Outcome Measure
Mean Activation of Frontostriatal and Prefrontal Brain Regions to disgusted facial expression in Social Anxiety [ Time Frame: Day 2 ]
Central Contacts
- Courtney Marcelino323-361-6456
- Bradley S Peterson, MD323-361-3654
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital Los Angeles | Los Angeles | California | 90027 |
Find similar trials in Los Angeles, CA
Related Studies
- A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety DisorderPHASE2 · Recruiting · VistaGen Therapeutics, Inc. · Sherman Oaks, California
- Computer - Based Treatment for Social Anxiety DisorderRecruiting · New York State Psychiatric Institute · New York, New York
- Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for ComorbidityRecruiting · University of Minnesota · Minneapolis, Minnesota
- Respiratory Training in the Treatment of Transdiagnostic Pathological AnxietyRecruiting · University of Texas at Austin · Austin, Texas